Physician profile
Vincent Morelli
NPI 1285753293
$433.49
in general payments reported to CMS, 2019-2025
12 companies · $22.91 in 2025
The $22.91 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.20 · 2020: $103 · 2021: $130 · 2022: $13.05 · 2023: $81.00 · 2024: $59.46 · 2025: $22.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $198.88 | 2020-2022 | |
| Neurelis, INC. | $36.14 | 2023-2024 | Valtoco |
| Novo Nordisk INC | $24.99 | 2023 | |
| Abbvie INC. | $24.42 | 2021 | |
| Sanofi-Aventis U.S. LLC | $23.71 | 2024 | |
| Hologic Sales and Service, LLC | $22.91 | 2025 | Aptima |
| Esperion Therapeutics, INC. | $22.62 | 2020 | |
| Janssen Pharmaceuticals, INC | $20.01 | 2023 | Xarelto |
| Xeris Pharmaceuticals, INC. | $19.81 | 2023 | Gvoke Hypopen |
| Depuy Synthes Sales INC. | $15.80 | 2024 | Monovisc, Orthovisc |
| E.R. Squibb & Sons, L.L.C. | $13.39 | 2019 | |
| Zyla Life Sciences, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Morelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.